Screen time in 36-month-olds at increased likelihood for ASD and ADHD.


Journal

Infant behavior & development
ISSN: 1934-8800
Titre abrégé: Infant Behav Dev
Pays: United States
ID NLM: 7806016

Informations de publication

Date de publication:
11 2020
Historique:
received: 24 02 2020
revised: 05 08 2020
accepted: 17 08 2020
pubmed: 2 9 2020
medline: 8 6 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

We examined the relationship between video-based media viewing (screen time), behavioral outcomes, and language development in 120 36-month-old children with a family history of Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD) or no family history of either condition. Participants were classified into one of three diagnostic groups: ASD (n = 20), ADHD Concerns (children with elevated ADHD symptoms; n = 14), or Comparison (n = 86). Children in the ADHD Concerns group spent more time viewing screen media than Comparison children. Increased screen time was associated with lower receptive and expressive language scores across groups. Future longitudinal studies are needed to determine the direction of effects and causality.

Identifiants

pubmed: 32871326
pii: S0163-6383(20)30112-0
doi: 10.1016/j.infbeh.2020.101484
pmc: PMC7736468
mid: NIHMS1623655
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

101484

Subventions

Organisme : NIMH NIH HHS
ID : K99 MH106642
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103526
Pays : United States
Organisme : NIMH NIH HHS
ID : R00 MH106642
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH099046
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Biol Psychiatry. 2005 Jun 1;57(11):1313-23
pubmed: 15950004
J Child Psychol Psychiatry. 2016 May;57(5):585-95
pubmed: 26709141
JAMA Pediatr. 2019 Apr 1;173(4):391-393
pubmed: 30776061
Child Adolesc Psychiatr Clin N Am. 2018 Apr;27(2):183-191
pubmed: 29502745
Eur Child Adolesc Psychiatry. 2010 Mar;19(3):281-95
pubmed: 20148275
PLoS One. 2019 Apr 17;14(4):e0213995
pubmed: 30995220
J Abnorm Child Psychol. 2014 Aug;42(6):993-1004
pubmed: 24343794
Pediatrics. 2004 Apr;113(4):708-13
pubmed: 15060216
JAMA Pediatr. 2014 May;168(5):485-92
pubmed: 24639016
Top Lang Disord. 2012 Jul;32(3):228-246
pubmed: 25505812
J Autism Dev Disord. 2013 Mar;43(3):673-86
pubmed: 22918859
J Pediatr. 2007 Oct;151(4):364-8
pubmed: 17889070
J Clin Child Adolesc Psychol. 2018 Sep-Oct;47(5):737-744
pubmed: 27732091
JAMA Pediatr. 2020 Jan 1;174(1):e193869
pubmed: 31682712
Pediatrics. 2011 Sep;128(3):e488-95
pubmed: 21844053
Pediatrics. 2013 Feb;131(2):e390-7
pubmed: 23296440
Pediatrics. 2007 Sep;120(3):532-7
pubmed: 17766526
J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):300-308.e1
pubmed: 23452686
Acad Pediatr. 2016 Mar;16(2):122-8
pubmed: 26525987
J Autism Dev Disord. 2007 Jan;37(1):145-57
pubmed: 17216560
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2
pubmed: 24342384
JAMA Pediatr. 2019 Feb 1;173(2):147-152
pubmed: 30535156
Pediatrics. 2014 May;133(5):e1172-8
pubmed: 24733868
Pediatrics. 2016 Nov;138(5):
pubmed: 27940793
Arch Pediatr Adolesc Med. 2010 Dec;164(12):1105-11
pubmed: 21135338
J Dev Behav Pediatr. 2019 May;40(4):303-311
pubmed: 30908423
PLoS One. 2015 Mar 18;10(3):e0120663
pubmed: 25785449
BMC Pediatr. 2012 May 14;12:50
pubmed: 22583686
BMJ Open. 2019 Jan 3;9(1):e023191
pubmed: 30606703
Clin Pediatr (Phila). 2013 Sep;52(9):857-65
pubmed: 23820003
Eur Child Adolesc Psychiatry. 2017 May;26(5):541-548
pubmed: 27822641
J Paediatr Child Health. 2017 Apr;53(4):333-338
pubmed: 28168778
Infant Behav Dev. 2015 Feb;38:20-6
pubmed: 25544743
Child Dev. 2009 Sep-Oct;80(5):1350-9
pubmed: 19765004
J Neurodev Disord. 2018 Oct 22;10(1):29
pubmed: 30348077
Child Dev. 2014 May-Jun;85(3):956-970
pubmed: 24112079
J Autism Dev Disord. 2020 Jan 23;:
pubmed: 31974800
JAMA Pediatr. 2019 Mar 1;173(3):244-250
pubmed: 30688984

Auteurs

Monique Moore Hill (MM)

Department of Psychiatry & Behavioral Sciences, MIND Institute, University of California, Davis, United States. Electronic address: myhill@ucdavis.edu.

Devon Gangi (D)

Department of Psychiatry & Behavioral Sciences, MIND Institute, University of California, Davis, United States.

Meghan Miller (M)

Department of Psychiatry & Behavioral Sciences, MIND Institute, University of California, Davis, United States.

Sabrina Mohamed Rafi (SM)

Department of Psychiatry & Behavioral Sciences, MIND Institute, University of California, Davis, United States.

Sally Ozonoff (S)

Department of Psychiatry & Behavioral Sciences, MIND Institute, University of California, Davis, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH